Media portrayal of herbal remedies versus pharmaceutical clinical trials: Impacts on decision

Medicine and Law

Volumn 26, Issue 2, 2007, Pages 363-373

  Bubela, T ^a   Koper, M ^b   Boon, H ^c   Caulfield, T ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Clinical trial; Complementary and alternative medicine; Conflict of interest; Knowledge translation; Media coverage; Natural health product regulation; Pharmaceutical; Research funding; Risk

Indexed keywords

HERBACEOUS AGENT;

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONFLICT OF INTEREST; CONSUMER; DRUG INDUSTRY; EUROPE; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH EDUCATION; HUMAN; MASS MEDIUM; MEDICAL DECISION MAKING; MEDICAL ERROR; MEDICAL INFORMATION; NORTH AMERICA; PHYSICIAN; POLITICAL SYSTEM; QUALITY CONTROL; SOCIOECONOMICS;

EID: 34447265266     PISSN: 07231393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. E. Ernst & A. Fugh-Berman, Complementary and Alternative Medicine: What is it all about?, 59 Occup Environ. Med. 140 (2002).
2. David M. Eisenberg et al., Trends in Alternative Medicine Use in the United States, 1990-1997: Results of a Follow-up National Survey, 280 JAAM 1569 (1998).
3. Eisenberg, id.
4. M.J. Emslie et al., Changes in Public Awareness of, Attitudes to, and Use of Complementary Therapy in North East Scotland: Surveys in 1993 and 1999, 10 Complementary Therapies in Medicine 148 (2002)
5. Jungwee Park, Use of Alternative Health Care, 16 Health Reports 39 (2005).
6. Eisenberg, id.
7. Park, supra note 3.
8. T.J. Kaptchuk & David M. Eisenberg, The Persuasive Appeal of Alternative Medicine, 129 Ann. Intern. Med. 1061 (1998).
9. S.C. Piscitelli et al., Indinavir Concentrations and St John's Wort, 355 Lancet 547 (2000)
10. F. Ruschitzka et al., Acute Heart Transplant Rejection Due to Saint John's Wort, 355 Lancet. 548 (2000)
11. E. Ernst, The Efficacy of Herbal Medicine - An Overview, 19 Fundam. Clin. Pharmacol. 405 (2005).
12. John A. Astin, Why Patients Use Alternative Medicine, 279 JAMA 1548 (1998).
13. Id.
14. Alison Williams, The Diffusion of Alternative Health Care: As Case Study of Chiropractic and Naturopathic Practices, 44 Canadian Geographer 152 (2000).
15. E. Ernst & Katja Schmidt, Health Risks Over the Internet: Advice Offered by "Medical Herbalists" to a Pregnant Woman, 152 Wien. Med. Wschr. 190 (2002)
16. E. Ernst & N.C. Armstrong, Lay Books on Complementary/Alternative Medicine: A Risk Factor for Good Health?, 11 International Journal of Risk & Safety in Medicine 209 (1998).
17. Clare Bowerman, Confessions of a Former Alternative Health Journalist, 11 Skeptic 60 (2004)
18. E. Ernst & Katja Schmidt, "Alternative" Cures for Depression - How Safe are Web Sites?, 129 Psychiatry Research 297 (2004)
19. Ernst & Schmidt, supra note 11.
20. S.C. Piscitelli et al., Indinavir Concentrations and St John's Wort, 355 Lancet 547 (2000)
21. F. Ruschitzka et al., Acute Heart Transplant Rejection Due to Saint John's Wort, 355 Lancet 548 (2000)
22. E. Ernst, The Efficacy ofHerbal Medicine - An Overview, 19 Fundarn. Clin. Pharmacol. 405(2005).
23. T.J. Kaptchuk & D.M. Eisenberg, The Persuasive Appeal of Alternative Medicine, 129 Ann. Intern. Med. 1061 (1998).
24. Joanne Barnes et al., Different Standards for Reporting ADRs to Herbal Remedies and Conventional OTC Medicines: Face-to-face Interviews with 515 Users of Herbal Remedies, 45 Br. J Clin. Pharmacol. 496 (1998).
25. Id.
26. Joanne Barnes et al., Articles on Complementary Medicine in the Mainstream Medical Literature, 159 Arch. Intern. Med. 1721 (1999).
27. Gordon S. Jepson, Regulation of Natural Health Products in Canada, 57 Food & Drug L.J. 59 (2002).
28. Timothy Caulfield & Suzanne DeBow, A Systematic Review of How Homeopathy is Represented in Conventional and CAM Peer Reviewed Journals, 5 BMC Complementary and Alternative Medicine 12 (2005).
29. Barnes, supra note 17
30. E. Ernst & K.L. Resch, Reviewer Bias Against the Unconventional? A Randomized Double-blind Study of Peer Review, 7 Complementary Therapies in Medicine 19 (1999).
31. Id.
32. D.F. Thompson, Understanding Financial Conflicts of Interest, 329 N. Engl J Med. 573 (1993).
33. Jepson, supra note 18.
34. Health Canada, Natural Health Products Research Program (NBPRP) - Conference Support - Request for Proposal, httv://www.hc-sc.2c.ca/ sr-sr/finance/nhprp-prpsn/finance/resear-recher confer support-soutien e.html.
35. Tania Bubela & Timothy Caulfield, Does the Print Media Hype Genetic Research?: A Comparison of Newspaper Stories and Peer Reviewed Research Papers, 170 CMAJ 1399(2004).
36. Aljandro R. Jadad et al., Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?, 17 Controlled Clinical Trials 1 (1996).
37. Bowerman, supra note 12.
38. Council on Scientific Affairs, American Medical Association, Muence of Funding Source on Outcome, Validity, and Reliability of Pharmaceutical Research (presented as C SA Report 10 at the 2004 AMA Annual Meeting, June 2004).
39. Caulfield & DeBow, supra note 19.
40. Jadad, supra note 26.
41. Klaus Linde et al., The Methodological Quality PF Randomized Controlled Trials of Homeopathy, Herbal Medicines and Acupuncture, 30 International Journal of Epidemiology 526(2001).
42. Id.
43. Neil Holtzman et al., The Quality of Media Reports on Discoveries Related to Human Genetic Diseases, 8 Community Genetics 133 (2005)
44. See also, Bubela & Caulfield, supra note 25.
45. Holtzman, id.
46. S.C. Piscitelli et al., Indinavir Concentration and St John's Wort, 355 Lancet 547 (2000)
47. F. Ruschitzka et al., A cute Heart Transplant Rejection Due to saint John's Wort, 355 Lancet 548 (2000)
48. Ernst, supra note 13.
49. Bubela & Caufield, supra note 25.